share_log

シンバイオ製薬---続落、第三者割当による無担保転換社債型新株予約権付社債の発行を嫌気

Sinbio Pharmaceuticals - Continued decline due to discontent with the issuance of unsecured Convertible Bonds with subscription rights through third-party allotment.

Fisco Japan ·  Dec 26 12:35

Continuing to decline. Announced the issuance of unsecured Convertible Bonds with subscription rights through third-party allocation, being pressured by selling due to concerns about dilution. A contract has been concluded with Cantor Fitzgerald Europe regarding the establishment of a program for issuing subscription rights attached bonds. The total amount to be paid for the subscription rights attached bonds to be issued under this program is up to 2.4 billion yen, and it will be issued through a total of four allocations from the 4th, 5th, 6th, and 7th subscription rights attached bonds third-party allocations. The net proceeds raised are planned to be used for the development of the antiviral drug brinavibrin.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment